Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2026 Filed Oct 9, 2026 23:07 UTC |
RIKER LAURENSenior Vice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001628280-26-065566 · wk-form4_1791587267.xml · derivative · entry 3 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2026-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years. F1 · derivative.underlying_shares: The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. Read SEC document |
| October 08, 2026 Filed Oct 9, 2026 23:07 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 6,000 | $36.32 | $217,920.00 |
DisclosureSEC source: 0001628280-26-065566 · wk-form4_1791587267.xml · nonDerivative · entry 2 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,284.242 F1 · shares: The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. Read SEC document |
| October 08, 2026 Filed Oct 9, 2026 23:07 UTC |
RIKER LAURENSenior Vice President, Finance
|
Exercise / conversionCommon Stock | 6,000 | $32.35 | $194,100.00 |
DisclosureSEC source: 0001628280-26-065566 · wk-form4_1791587267.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,284.242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 21:21 UTC |
SLONIN JONATHANChief Medical Officer
|
SaleCommon Stock | 3,040 | $23.23 | $70,619.20 |
DisclosureSEC source: 0001628280-26-057759 · wk-form4_1787088074.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,383.646 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025. F2 · balance_after: Includes 511.471 shares of common stock acquired under the issuer's employee stock purchase plan in June 2026. Read SEC document |
| June 11, 2026 Filed Jun 13, 2026 01:07 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 6,115 | $23.50 | $143,702.50 |
DisclosureSEC source: 0001628280-26-043009 · wk-form4_1781312864.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,284.242 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:07 UTC |
Hirawat SamitDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043010 · wk-form4_1781312871.xml · derivative · entry 2 Hirawat Samit · CIK 0001781290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:07 UTC |
Hirawat SamitDirector
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043010 · wk-form4_1781312871.xml · nonDerivative · entry 1 Hirawat Samit · CIK 0001781290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,405 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:06 UTC |
Froimson MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043003 · wk-form4_1781312816.xml · derivative · entry 2 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:06 UTC |
Froimson MarkDirector
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043003 · wk-form4_1781312816.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,541 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
WIGGANS THOMAS GDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,675 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043007 · wk-form4_1781312848.xml · derivative · entry 1 WIGGANS THOMAS G · CIK 0001208907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,675 Underlying: Common Stock · 32,675 shares Expires 2036-06-10 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly installments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:06 UTC |
Brege LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043002 · wk-form4_1781312808.xml · derivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:06 UTC |
Brege LauraDirector
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043002 · wk-form4_1781312808.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,120 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043008 · wk-form4_1781312856.xml · derivative · entry 2 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043008 · wk-form4_1781312856.xml · nonDerivative · entry 1 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,059 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
Young AlethiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043006 · wk-form4_1781312840.xml · derivative · entry 2 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
Young AlethiaDirector
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043006 · wk-form4_1781312840.xml · nonDerivative · entry 1 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,798 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
YANG MICHAEL J.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043005 · wk-form4_1781312832.xml · derivative · entry 2 YANG MICHAEL J. · CIK 0001702283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
YANG MICHAEL J.Director
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043005 · wk-form4_1781312832.xml · nonDerivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,798 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
BIGAL MARCELODirector
|
GrantStock Option (Right to Buy) · Derivative | 10,891 | $0.00 Strike: $23.42 | $0.00 |
DisclosureSEC source: 0001628280-26-043004 · wk-form4_1781312824.xml · derivative · entry 2 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,891 Underlying: Common Stock · 10,891 shares Expires 2036-06-10 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:07 UTC |
BIGAL MARCELODirector
|
GrantCommon Stock | 6,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043004 · wk-form4_1781312824.xml · nonDerivative · entry 1 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,798 F1 · shares: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:57 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 10,259 | $22.27 | $228,467.93 |
DisclosureSEC source: 0001628280-26-041330 · wk-form4_1780696617.xml · nonDerivative · entry 2 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,062 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on September 10, 2025. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:57 UTC |
SLONIN JONATHANChief Medical Officer
|
Tax withholdingCommon Stock | 4,728 | $22.32 | $105,528.96 |
DisclosureSEC source: 0001628280-26-041331 · wk-form4_1780696625.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,912.175 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:57 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Tax withholdingCommon Stock | 8,528 | $22.32 | $190,344.96 |
DisclosureSEC source: 0001628280-26-041330 · wk-form4_1780696617.xml · nonDerivative · entry 1 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,321 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:57 UTC |
RIKER LAURENSenior Vice President, Finance
|
Tax withholdingCommon Stock | 3,187 | $22.32 | $71,133.84 |
DisclosureSEC source: 0001628280-26-041332 · wk-form4_1780696632.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,399.242 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| April 23, 2026 Filed Apr 25, 2026 00:41 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,941 | $0.00 Strike: $16.45 | $0.00 |
DisclosureSEC source: 0001628280-26-027287 · wk-form4_1777077683.xml · derivative · entry 3 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 12,941 shares Expires 2034-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F3 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. F1 · derivative.underlying_shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 23, 2026 Filed Apr 25, 2026 00:41 UTC |
Cross ShawnChief Financial Officer
|
SaleCommon Stock | 12,941 | $25.16 | $325,595.56 |
DisclosureSEC source: 0001628280-26-027287 · wk-form4_1777077683.xml · nonDerivative · entry 2 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,341 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 23, 2026 Filed Apr 25, 2026 00:41 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionCommon Stock | 12,941 | $16.45 | $212,879.45 |
DisclosureSEC source: 0001628280-26-027287 · wk-form4_1777077683.xml · nonDerivative · entry 1 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 22, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $16.45 | $0.00 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · derivative · entry 9 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,941 Underlying: Common Stock · 1,500 shares Expires 2034-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. F1 · derivative.underlying_shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 22, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
SaleCommon Stock | 1,500 | $25.01 | $37,515.00 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · nonDerivative · entry 6 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,341 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive. Read SEC document |
| April 22, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionCommon Stock | 1,500 | $16.45 | $24,675.00 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · nonDerivative · entry 5 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,845 | $0.00 Strike: $16.45 | $0.00 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · derivative · entry 8 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,441 Underlying: Common Stock · 2,845 shares Expires 2034-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. F1 · derivative.underlying_shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
SaleCommon Stock | 2,845 | $25.01 | $71,153.45 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · nonDerivative · entry 4 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,341 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive. Read SEC document |
| April 21, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionCommon Stock | 2,845 | $16.45 | $46,800.25 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · nonDerivative · entry 3 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,714 | $0.00 Strike: $16.45 | $0.00 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · derivative · entry 7 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,286 Underlying: Common Stock · 7,714 shares Expires 2034-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. F1 · derivative.underlying_shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
SaleCommon Stock | 7,714 | $25.14 | $193,929.96 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · nonDerivative · entry 2 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,341 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 00:03 UTC |
Cross ShawnChief Financial Officer
|
Exercise / conversionCommon Stock | 7,714 | $16.45 | $126,895.30 |
DisclosureSEC source: 0001628280-26-026669 · wk-form4_1776902593.xml · nonDerivative · entry 1 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 21:43 UTC |
SLONIN JONATHANChief Medical Officer
|
SaleCommon Stock | 3,261 | $22.82 | $74,416.02 |
DisclosureSEC source: 0001628280-26-019891 · wk-form4_1773956586.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,640.175 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 17:43 UTC |
Froimson MarkDirector
|
SaleCommon Stock | 500 | $21.81 | $10,905.00 |
DisclosureSEC source: 0001628280-26-019890 · wk-form4_1773956578.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,136 Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:01 UTC |
SLONIN JONATHANChief Medical Officer
|
GrantCommon Stock | 54,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008075 · wk-form4_1771016513.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,901.175 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:02 UTC |
Cross ShawnChief Financial Officer
|
GrantCommon Stock | 49,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008080 · wk-form4_1771016540.xml · nonDerivative · entry 1 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,341 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:02 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantCommon Stock | 54,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008078 · wk-form4_1771016534.xml · nonDerivative · entry 1 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,849 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:02 UTC |
Teehan BrendanChief Commercial Officer
|
GrantCommon Stock | 51,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008077 · wk-form4_1771016527.xml · nonDerivative · entry 1 Teehan Brendan · CIK 0001891900 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,934.268 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:02 UTC |
RIKER LAURENSenior Vice President, Finance
|
GrantCommon Stock | 19,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008076 · wk-form4_1771016519.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,586.242 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:01 UTC |
Lee Frank D.Director · Chief Executive Officer
|
GrantCommon Stock | 261,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008074 · wk-form4_1771016507.xml · nonDerivative · entry 1 Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 660,830.841 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 23:24 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 13,137 | $20.53 | $269,702.61 |
DisclosureSEC source: 0001628280-26-005157 · wk-form4_1770161039.xml · nonDerivative · entry 2 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,303 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 23:24 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 4,000 | $20.81 | $83,240.00 |
DisclosureSEC source: 0001628280-26-005158 · wk-form4_1770161045.xml · nonDerivative · entry 2 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,313.242 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.35 to $21.28, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 23:23 UTC |
SLONIN JONATHANChief Medical Officer
|
Tax withholdingCommon Stock | 6,168 | $20.54 | $126,690.72 |
DisclosureSEC source: 0001628280-26-005155 · wk-form4_1770161031.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,355.175 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 23:24 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Tax withholdingCommon Stock | 17,134 | $20.54 | $351,932.36 |
DisclosureSEC source: 0001628280-26-005157 · wk-form4_1770161039.xml · nonDerivative · entry 1 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,440 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 23:24 UTC |
RIKER LAURENSenior Vice President, Finance
|
Tax withholdingCommon Stock | 2,751 | $20.54 | $56,505.54 |
DisclosureSEC source: 0001628280-26-005158 · wk-form4_1770161045.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,313.242 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 23:23 UTC |
Teehan BrendanChief Commercial Officer
|
Tax withholdingCommon Stock | 5,182 | $20.54 | $106,438.28 |
DisclosureSEC source: 0001628280-26-005154 · wk-form4_1770161023.xml · nonDerivative · entry 1 Teehan Brendan · CIK 0001891900 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,220.268 F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.